Key Highlights
- Two Pennsylvania residents died of measles, the first US deaths from the disease reported in 2026 and the first in the state in 35 years.
- The CDC reported 2,777 confirmed measles cases nationwide as of August 20, a 35-year high, with 94% of cases tied to 36 outbreaks reported this year.
- US measles hospitalizations stand at 169 this year with two deaths, compared with 243 hospitalizations and three deaths in all of 2025.
- National MMR vaccination coverage among kindergartners has declined from 95.2% in the 2019-2020 school year to 92.7% in 2023-2024, below the 95% threshold needed for herd immunity.
First US Measles Deaths of the Year Reported in Pennsylvania
Two Pennsylvania residents have died of measles, health officials said, marking the first US deaths from the disease reported in 2026 and the first in the state in 35 years. A decline in childhood vaccination rates in recent years, fueled in part by unscientific claims that the Vaccine is unsafe, has contributed to larger and more frequent outbreaks nationwide.
Measles has surged in the United States this year, with the CDC reporting 2,777 confirmed cases nationwide as of August 20, a 35-year high reached in July. There have been 36 new outbreaks reported in 2026, and 94% of confirmed cases, 2,614 of the 2,777 total, are outbreak-associated, with 1,239 tied to outbreaks that began this year and 1,375 linked to outbreaks that started in 2025. By comparison, 2,289 confirmed cases were reported for all of 2025, with roughly 11% requiring hospitalization. US measles-related hospitalizations this year stand at 169 with two deaths, compared with 243 hospitalizations and three deaths in 2025. The CDC estimates that about 1 in 5 unvaccinated people who contract measles will require hospitalization.
Why Measles Remains a Serious Health Risk
In the decade before a vaccine became available in 1963, the US recorded 3 million to 4 million measles cases annually, mostly among children, with 48,000 hospitalizations and 400 to 500 deaths each year. Complications from measles can include ear infections, hearing loss, pneumonia, croup, diarrhea, blindness, and swelling of the brain. Even healthy children can develop serious illness or die from the disease, and in unvaccinated pregnant women, measles may cause premature birth or a low-birthweight baby.
Vaccination Remains the Only Proven Prevention
The best protection against measles is vaccination, either as a standalone shot or as part of the combined Measles-Mumps-Rubella, or MMR, vaccine, or the Measles-Mumps-Rubella-Varicella, or MMRV, vaccine. No vitamins or drugs have been shown to prevent measles. Two doses of the MMR vaccine provide 97% protection against the virus, with children typically receiving their first dose at 12 to 15 months and a second between ages 4 and 6.
Adults born before 1957 are presumed to have immunity, as most had measles during childhood. Adults who are unsure whether they were vaccinated should get a dose, according to the CDC, which also recommends a booster for adults who received boosters many years ago and may face exposure during an outbreak.
Declining Vaccination Rates Have Eroded Herd Immunity
At least 95% of kindergarten-age children need to be vaccinated against measles to achieve herd immunity, a threshold that protects both the vaccinated population and those unable to receive the vaccine. That goal has become harder to reach in recent years as public figures have promoted theories, unsupported by scientific evidence, linking childhood vaccines to autism and other health risks. The theory traces back to a long-discredited study of 12 children conducted in the late 1990s by British researcher Andrew Wakefield, which claimed a connection between the measles vaccine and autism. Rigorous subsequent research has found no such link between vaccines, or their components, and autism.
National vaccination coverage among US kindergartners fell from 95.2% in the 2019-2020 school year to 92.7% in 2023-2024, according to the CDC. The Texas county at the center of a major 2025 measles outbreak had an 80% vaccination rate among kindergartners in 2023-24. Vaccination rates below the herd immunity threshold leave unvaccinated individuals, including infants and people with immune disorders, more vulnerable to infection.
How Measles Spreads and Is Treated
Measles spreads through respiratory droplets from coughing or sneezing, and virus particles can remain suspended in the air for up to two hours. Up to 90% of unvaccinated people near an infected person will become infected. Symptoms, including cough, runny nose, inflamed eyes, sore throat, fever, and a red, blotchy skin rash, typically appear 10 to 21 days after exposure. Because infected individuals can unknowingly spread the disease during that incubation period, health experts recommend a 21-day Quarantine for unvaccinated people who have been exposed.
There are no specific drugs to treat measles. Treatment focuses on easing symptoms and limiting complications, with the World Health Organization recommending rest, hydration, and fever reducers such as ibuprofen or acetaminophen. Antibiotics can treat secondary infections such as pneumonia or ear and eye infections, while steroids are sometimes used for a rare complication involving brain swelling, though they can also weaken the immune system's response to the virus.
Vitamin A supplements, which have been raised as a potential alternative to vaccination, cannot prevent measles. Studies show high doses of vitamin A can reduce severe complications in children with measles, though this research is based largely on low-income countries where malnutrition is common. According to Dr. Sean O'Leary, chair of the Infectious Diseases Committee at the American Academy of Pediatrics, evidence supporting vitamin A use for measles patients in developed countries is weak. Both the World Health Organization and the American Academy of Pediatrics caution that vitamin A doses recommended for measles must be administered under medical supervision due to the risk of toxicity.
Conclusion
The first US measles deaths of 2026 mark a grim milestone in an outbreak year already defined by the highest case count in 35 years, underscoring the direct public health consequences of declining childhood vaccination rates. With herd immunity thresholds unmet in many communities and cases increasingly outbreak-associated rather than isolated, health officials are likely to continue emphasizing vaccination as the primary tool for containment, even as public skepticism toward childhood Immunization persists in parts of the country.






Please wait processing your request...